In recent years, the concept of patient centeredness has gained significant traction across various domains of healthcare. This paradigm shift has prompted a critical examination of how we evaluate the value of healthcare technologies and interventions. One area that warrants particular attention is Health Technology Assessment (HTA), a process widely used to inform decision making regarding the adoption and reimbursement of interventions (drugs.technologies.devices). Recognizing the need to align HTA decision making with the needs and values of patients, there is a growing call to establish a patient centered approach to HTA. Reorienting the evaluation process to reflect the diverse perspectives, experiences, and priorities (values, unmet needs) of patients, empowering them as active partners in shaping healthcare policy and decision making.